Skip to content
Biodatica
Start free

Investigator

Benjamin Elison Gewurz

GORDON RESEARCH CONFERENCES · funded by NCI, NIAID, NIDCR

Companies
1

Resolved onto their grants.

Grants
9

Federal awards on file.

Non-dilutive funding
$4.0M

Summed across those awards.

First award
Sep 19, 2019

Latest May 9, 2026.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R13

    2026 Nasopharyngeal Carcinoma Gordon Research Conference

    $15k

    May 9, 2026NCIGORDON RESEARCH CONFERENCESNIH RePORTER · 11319955 (opens the source filing in a new tab)

  2. R21

    Systematic CRISPR Analysis of EBV Lymphoma Resistance Pathways to Natural Killer Cell Lysis

    $269k

    Jul 5, 2024NIAIDBRIGHAM AND WOMEN'S HOSPITALNIH RePORTER · 11132956 (opens the source filing in a new tab)

  3. R01

    Epstein-Barr Virus Driven Tonsillar Versus Peripheral B-cell One-Carbon Metabolic Network Remodeling

    $508k

    May 6, 2024NIDCRBRIGHAM AND WOMEN'S HOSPITALNIH RePORTER · 11084469 (opens the source filing in a new tab)

  4. R01

    Epstein-Barr Virus Driven Tonsillar Versus Peripheral B-cell One-Carbon Metabolic Network Remodeling

    $508k

    May 6, 2024NIDCRBRIGHAM AND WOMEN'S HOSPITALNIH RePORTER · 11312695 (opens the source filing in a new tab)

  5. P01

    Methionine and PI3K Metabolism Drive CIMP in EBV Epithelial Cancers

    $480k

    May 11, 2023NCIWISTAR INSTITUTENIH RePORTER · 11085167 (opens the source filing in a new tab)

  6. P01

    Methionine and PI3K Metabolism Drive CIMP in EBV Epithelial Cancers

    $465k

    May 11, 2023NCIWISTAR INSTITUTENIH RePORTER · 11334347 (opens the source filing in a new tab)

  7. R01

    Regulation of the Epstein-Barr Virus Lytic Switch

    $506k

    Jul 6, 2021NIAIDBRIGHAM AND WOMEN'S HOSPITALNIH RePORTER · 11113885 (opens the source filing in a new tab)

  8. R01

    Epstein-Barr virus LMP1 mediated oncogenicity

    $616k

    Sep 19, 2019NCIBRIGHAM AND WOMEN'S HOSPITALNIH RePORTER · 11187589 (opens the source filing in a new tab)

  9. R01

    Epstein-Barr virus LMP1 mediated oncogenicity

    $606k

    Sep 19, 2019NCIBRIGHAM AND WOMEN'S HOSPITALNIH RePORTER · 11306698 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources